46 related articles for article (PubMed ID: 12630023)
1. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy.
Simonovic SZ; Mihaljevic O; Majstorovic I; Djurdjevic P; Kostic I; Djordjevic OM; Teodorovic LM
Cancer Immunol Immunother; 2015 Jan; 64(1):75-82. PubMed ID: 25297452
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn.
Scheid A; Borriello F; Pietrasanta C; Christou H; Diray-Arce J; Pettengill MA; Joshi S; Li N; Bergelson I; Kollmann T; Dowling DJ; Levy O
Front Immunol; 2018; 9():29. PubMed ID: 29416539
[TBL] [Abstract][Full Text] [Related]
4. Human defensins and Th-1 cytokines in hepatitis C viral infection.
Owusu DO; Owusu M; Owusu BA
Pan Afr Med J; 2020; 37():103. PubMed ID: 33425136
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory effects of RACK1 pseudosubstrate in human leukocytes obtained from young and old donors.
Corsini E; Galbiati V; Pinto A; Davin A; Polito L; Guaita A; Racchi M
Oncotarget; 2015 Mar; 6(9):6524-34. PubMed ID: 25779661
[TBL] [Abstract][Full Text] [Related]
6. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
7. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy.
Obaid A; Naz A; Ikram A; Awan FM; Raza A; Ahmad J; Ali A
Sci Rep; 2018 Jun; 8(1):8874. PubMed ID: 29891859
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.
Refaat B; El-Shemi AG; Ashshi A; Azhar E
Int J Clin Exp Med; 2015; 8(7):10284-303. PubMed ID: 26379820
[TBL] [Abstract][Full Text] [Related]
9. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.
Refaat B; Ashshi AM; El-Shemi AG; Azhar E
Mediators Inflamm; 2015; 2015():287640. PubMed ID: 25969625
[TBL] [Abstract][Full Text] [Related]
10. Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells.
Bunz H; Plankenhorn S; Klein R
Int J Nanomedicine; 2012; 7():4571-80. PubMed ID: 22942641
[TBL] [Abstract][Full Text] [Related]
11. Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.
Harp CT; Ireland S; Davis LS; Remington G; Cassidy B; Cravens PD; Stuve O; Lovett-Racke AE; Eagar TN; Greenberg BM; Racke MK; Cowell LG; Karandikar NJ; Frohman EM; Monson NL
Eur J Immunol; 2010 Oct; 40(10):2942-56. PubMed ID: 20812237
[TBL] [Abstract][Full Text] [Related]
12. Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection.
Yin LM; Zhu WF; Wei L; Xu XY; Sun DG; Wang YB; Fan WM; Yu M; Tian XL; Wang QX; Gao Y; Zhuang H
World J Gastroenterol; 2004 Aug; 10(16):2330-3. PubMed ID: 15285014
[TBL] [Abstract][Full Text] [Related]
13. Review of cytokine profiles in patients with hepatitis.
Sun QL; Ran W
World J Gastroenterol; 2004 Jun; 10(12):1709-15. PubMed ID: 15188491
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
[TBL] [Abstract][Full Text] [Related]
15. Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B.
Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
Hepatogastroenterology; 2001; 48(38):553-5. PubMed ID: 11379352
[TBL] [Abstract][Full Text] [Related]
16. TH1/TH2 serum cytokine profiles and soluble TNF-receptor response in patients with chronic hepatitis C during recombinant human interleukin-12 (rHuIL-12) treatment.
Teuber G; Rossol S; Lee JH; Dietrich CF; Zeuzem S
Z Gastroenterol; 2002 Jul; 40(7):487-95. PubMed ID: 12122596
[TBL] [Abstract][Full Text] [Related]
17. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.
Abayli B; Canataroğlu A; Akkiz H
Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531
[TBL] [Abstract][Full Text] [Related]
18. Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in chronic hepatitis C: a critical reappraisal.
Antonaci S; Piazzolla G; Napoli N; Vella FS; Fiore G; Schiraldi O
Microbios; 2001; 106(415):203-12. PubMed ID: 11522131
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 12 and innate molecules for enhanced mucosal immunity.
Boyaka PN; Lillard JW; McGhee J
Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
